Widely used in pharmaceutical synthesis, this compound serves as a key intermediate in cross-coupling reactions, particularly in the development of active pharmaceutical ingredients (APIs). Its boron-containing group enables Suzuki-Miyaura coupling, allowing efficient formation of carbon-carbon bonds with halogenated heteroaromatics. This makes it valuable in constructing complex molecules for drug discovery, especially in oncology and central nervous system therapies. The piperazine and pyrimidine moieties contribute to favorable pharmacokinetic properties, enhancing its utility in medicinal chemistry. It is also employed in the preparation of kinase inhibitors and other targeted therapies.